US2003194390A1PendingUtilityA1

Compositions useful for remodeling body spaces

Assignee: PROVASIS THERAPEUTICS INCPriority: Jan 28, 2000Filed: Dec 16, 2002Published: Oct 16, 2003
Est. expiryJan 28, 2020(expired)· nominal 20-yr term from priority
A61P 35/00A61P 9/00A61P 15/00A61K 31/12A61K 31/275A61L 31/048C09J 4/06A61K 31/78A61L 24/06A61P 15/18A61K 31/785C08F 267/06C09J 4/00A61K 33/243A61K 33/242
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition comprising of a monomer component comprised of at least one alkyl cyanoacrylate and at least one inhibitor, and a second component comprised of a resultant aggregate structure formed from an alkyl cyanoacrylate monomer, an alkyl esterified fatty acid and an opacificant agent where said composition forms a resultant aggregate structure when said composition contacts an anionic environment. The compositions are useful for filling, occluding, partially filling or partially occluding an unfilled volume or space in a mass in an anionic environment. The composition are also useful for ablating diseased or undesired tissue by cutting off the blood supply to the tissue.

Claims

exact text as granted — not AI-modified
We claim:  
     
         1 . A method of filling, occluding, partially filling or partially occluding an unfilled volume or space in a mass in an anionic environment comprising administering a composition comprising of a monomer component comprised of at least one alkyl cyanoacrylate and at least one inhibitor, and a second component comprised of a resultant aggregate structure formed from an alkyl cyanoacrylate monomer, an alkyl esterified fatty acid and an opacificant agent where said composition forms a resultant aggregate structure when said composition contacts an anionic environment with an administering device comprised, a means for stabilizing fluid flow distal or proximal to said space being treated, and a means for delivering said composition to said space.

Join the waitlist — get patent alerts

Track US2003194390A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.